The oncological effects of HER2 expression, particularly its downstream impact on the PI3K/Akt pathway (PI3K, Phosphoinositide 3-kinase; Akt, Protein kinase B), have been extensively studied in breast cancer [16, 17]. The gene discussed is AKT1; the disease is breast carcinoma.